Income Statement (TTM)
NextCure, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
|
|---|---|---|---|---|---|
| Revenue | 24 | 22 | 0 | 0 | 0 |
| Change (%) | -8.22 | -100.00 | NaN | NaN | |
| % of Revenue | 100.00 | 100.00 | |||
| Cost Of Sales | 46 | 47 | 36 | 49 | 50 |
| Change (%) | 1.55 | -22.72 | 36.69 | 1.74 | |
| % of Revenue | 188.02 | 208.03 | |||
| Gross Operating Profit | -21 | -24 | -36 | -49 | -50 |
| Change (%) | 12.65 | 48.81 | 36.69 | 1.74 | |
| % of Revenue | -88.02 | -108.03 | |||
| SG&A | 16 | 17 | 18 | 20 | 20 |
| Change (%) | 9.74 | 7.39 | 7.30 | 1.28 | |
| % of Revenue | 63.72 | 76.19 | |||
| R&D | 12 | ||||
| Change (%) | |||||
| % of Revenue | |||||
| OpEx | 61 | 64 | 67 | 69 | 70 |
| Change (%) | 3.62 | 4.82 | 3.23 | 1.61 | |
| % of Revenue | 251.74 | 284.22 | |||
| Operating Income | -37 | -41 | -67 | -69 | -70 |
| Change (%) | 11.42 | 61.72 | 3.23 | 1.61 | |
| % of Revenue | -151.74 | -184.22 | |||
| Interest Expense | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -12.44 | -0.00 | -0.00 | -0.00 | |
| % of Revenue | -0.86 | -0.82 | |||
| Net Income | -32 | -37 | -63 | -66 | -68 |
| Change (%) | 14.14 | 71.76 | 5.53 | 2.36 | |
| % of Revenue | -131.52 | -163.57 | |||
Source: Capital IQ
